INTRODUCTION {#S0001}
============

The ureteropelvic junction obstruction (UPJO) in adults is defined as a functional disorder of the transport of urine from the renal pelvis into the ureter, producing pyelic and calyceal dilatation of the affected kidney. Although the most common cause is a congenital alteration of the ureteropelvic junction, in which the obstruction is due to intrinsic fibrosis of a ureteral segment that becomes aperistaltic, other causes have been described from a ureteral origin (ureteral valves, anomalies in the insertion of the ureter) to extraureteral (adhesions, fibrosis, abnormal vessels) \[[@CIT0001]\].

Multiple surgical techniques have been described, having evolved considerably over the past 20 years with the advance of new technologies. Traditionally, treatment of UPJO was based on surgical open pyeloplasty \[[@CIT0002]\]. Anderson and Hynes open pyeloplasty consists mainly of the ablation of the ureteral stenosed segment, the removal of part of the dilated pelvis and the performance of a ureteral muco--mucosal anastomosis. The effectiveness of open pyeloplasty approaches 90%, but carries with it significant postoperative pain and a prolonged hospital stay \[[@CIT0003]\].

In recent years, many minimally invasive techniques have been developed; the laparoscopic and endoscopic approaches of UPJO have reduced the morbidity of open surgery. Laparoscopic pyeloplasty obeys the same rules as the open surgery described by Anderson--Hynes, benefiting from the advantages of minimally invasive surgery. The intervention may be performed by transperitoneal or retroperitoneal approach with similar results to open surgery according to several published series \[[@CIT0003]\].

Nowadays the assessment of overall renal function, the ureteropelvic anatomy and physiology is considered essential in the diagnostic process of UPJO, since these parameters determine the appropriate choice of the surgical technique to use. Diuretic renography is the most commonly used diagnostic tool to assess for UPJO \[[@CIT0004]\]. Technetium Tc 99m MAG3 is the radiopharmaceutical agent of choice for this purpose and has largely replaced Tc 99m diethylenetriamine pentaacetic acid (DTPA), because it has a better gamma image than DTPA, as well as a faster clearance rate and lower background activity. One advantage of DTPA is that it may be used to measure the glomerular filtration rate, but MAG3 scanning may provide differential renal function by comparing isotope uptake in both kidneys, which, in turn, is a reflection of renal blood flow.

The aim of this study is to observe the renal function using diuretic renography in short and medium follow--ups of patients after laparoscopic pyeloplasty.

MATERIAL AND METHODS {#S0002}
====================

We conducted a retrospective review of our series of laparoscopic pyeloplasties \[[@CIT0005]\], and applied the following selection criteria: 1) perform MAG3 diuretic renography at least twice during the follow--up, with a gap of 4--6 months between each; 2) have at least a one year follow--up. Having fulfilled these criteria, we selected 35 of the 62 patients.

Data analysis: Data was analysed at our hospital biostatistics section. Analyses were performed with SAS 9.1 and Enterprise Guide 3.0. Quantitative data were described by mean and standard deviation, and qualitative data by absolute frequencies and percentages.

To analyse the average change of all the measures over time (pre--surgery, at 6 months, one year, two years if possible), a mixed linear regression model was adjusted. Ninety--five percent confidence intervals (CI) were used. The statistical analyses were performed and p \<0.05 was considered significant.

RESULTS {#S0003}
=======

Demographic and surgical data for selected patients are shown in [Table 1](#T0001){ref-type="table"}. During follow--up, statistically significant improvement compared with the pre--surgical value was observed in diuretic renography of the operated kidney in all patients selected during the time of follow--up in terms of: 1) functional uptake ratio (FUR): pre--surgery: 41.17%, at 6 months: 45.15%, at 1 year: 47.42%, at 2 years: 55.50% (p \<0.003); 2) furosemide excretion: pre-- surgery: 21.23%, at 6 months: 53.35%, at 1 year: 56.35%, at 2 years: 51.6%, (p \<0.006) and 3) total excretion: pre surgery: 46.69%, at 6 months: 65.27%, at 1 year: 61.75%, 2 years: 62.20%; (p \<0.002) ([Table 2](#T0002){ref-type="table"}).

###### 

Patients data

  Patients Number    35                                                                                       
  ------------------ ----------------------------------------------------------------------------------- ---- ------
  Sex                Female                                                                              19   54.2
                     Male                                                                                16   45.7
  Diagnosis          Pain                                                                                22   62.8
                     Radiologic finding                                                                  10   28.5
                     Others                                                                              3    8.5
  Side               Right                                                                               21   60
                     Left                                                                                14   40
  Crossing Vessels   Yes                                                                                 20   57.1
                     No                                                                                  15   42.8
  Hospital Stay      3.50[a](#TF0001){ref-type="table-fn"} days ±1.27[b](#TF0002){ref-type="table-fn"}        

Mean

Standard deviation

###### 

Diuretic renography parameters

                            Pre--surgery   6 months    1 year      2 years     p value
  ------------------------- -------------- ----------- ----------- ----------- ---------
  Functional uptake ratio   41.17%         45.15%      47.42%      44.80%      0.003\*
  Spontaneous excretion     29.54%         31.00%      35.83%      35.14%      0.708
  Furosemide excretion      21.23%         53.35%      56.35%      51.60%      0.006\*
  Total excretion           22.52%         54.25%      56.07%      52.20%      0.002\*
  Excretion time            4.38 mins      5.92 mins   5.29 mins   2.95 mins   0.820

No statistically significant differences were found in the excretion time (p = 0.820) and spontaneous excretion (p = 0.708) parameters of the surgical--treated kidney compared with the contralateral kidney, after certifying the correction of the UPJO) ([Table 2](#T0002){ref-type="table"}).

By dividing patients in two age groups: \<40 years and \>40 years we found no statistically significant differences between them in relation to the improvement of the FUR; in both groups it improved equally ([Table 3](#T0003){ref-type="table"}).

###### 

Functional Uptake Ratio in patients \<40 years and \>40 years

                                       Pre--surgery   6 months   1 year   2 years   p value
  ------------------------------------ -------------- ---------- -------- --------- ---------
  Functional uptake ratio \<40 years   40.50%         44.22%     49.52%   52.62%    0.593
  Functional uptake ratio \>40 years   41.20%         44.93%     47.31%   47.52%    

The FUR prior to surgery in the operated kidney was divided and analyzed in two groups: \<40% and \>40%, finding significant improvement in the group with greater functional impairment (FUR \<40%): pre--surgery: 32.22%, at 6 months: 36.50%, at 1 year 41.75%; (p \<0.002) vs FUR \>40%: pre--surgery: 45.81%, at 6 months: 47.82%, at 1 year 47.28% (p = 0.07) ([Table 4](#T0004){ref-type="table"}).

###### 

Functional uptake ratio divided \<40% and \>40%

                                  Pre--surgery   6 months   1 year   p value   p value
  ------------------------------- -------------- ---------- -------- --------- ---------
  Functional uptake ratio \<40%   33.22%         36.50%     41.75%   0.002\*   0.593
  Functional uptake ratio \>40%   45.81%         47.82%     47.28%   0.07      

DISCUSSION {#S0004}
==========

The first laparoscopic pyeloplasty was described by Schuessler et al. \[[@CIT0006]\] in the early 90s. During the last decade, laparoscopic pyeloplasty has evolved in order to achieve the same results as open surgery, with lower rates of morbidity and complications \[[@CIT0007]\].

Our department has extensive experience in reconstructive surgery \[[@CIT0005], [@CIT0008]\] and laparoscopic pyeloplasty has become the technique of choice for the treatment of UPJO since 2004. The aim of this study was to observe the evolution of diuretic renography in patients undergoing this procedure and to measure the renal function recovery using diuretic renography in short and medium follow--ups.

Limited data is available to create guidelines to justify the long--term monitoring of patients undergoing laparoscopic procedures for UPJO, especially in adult patients. O\'Reilly and colleagues considered that if kidney drainage is normal, demonstrated by renography a year after the surgery, patients can be discharged \[[@CIT0009]\]. Soulie et al. \[[@CIT0010]\], in their study, proposed follow--up of patients at the first and third months after surgery with intravenous urography (IVU) and diuretic renography, and then yearly with ultrasound for at least three years. In another study, Doo CK et al. \[[@CIT0011]\] recommended performing any imaging test during 2 or 3 years to find the rare situation of re--obstruction of the ureteropelvic junction. Dimarco et al. \[[@CIT0012]\] conclude in their study that failures continue to appear after 5 and 10 years, and patients should be followed accordingly.

Renogram curves of uptake and drainage of MAG3 have been defined by O\'Reilly et al. \[[@CIT0013]\]. Normally, the time required for clearance of 50% (t½) of the accumulated radionuclide is \<10 min, while a t½ of \>20 min is suggestive, but not diagnostic, of obstruction. The protocol for this test should be carefully observed, hydrating the patient before the injection of radioisotope and setting the necessary time between injection and imaging \[[@CIT0014]\].

Our results have shown that MAG3 diuretic renography is the best tool in the follow--up of patients with UPJO treated by laparoscopic pyeloplasty, because it diagnoses the presence of pre--surgery obstruction; and also shows the success of surgery in all patients, since the first diuretic renography is performed in the follow--up (within 6 months) demonstrated by the statistically significant improvements in the different excretion parameters. The most important finding of our study is that after one year of follow--up, a statistically significant improvement of the FUR is shown compared with the pre--surgery value, which means that there is a functional recovery of the affected kidney. The recovery of the FUR is evident in those kidneys with FUR lower than 40%, because if the FUR is worse, we may expect a greater improvement.

We have investigated whether age is an independent factor for renal function recovery by dividing the patients into two groups (\<40 years and \>40 years). We have not found a significant difference between the groups, so we recommend performing this procedure regardless of the patient\'s age. There are multiple articles that have described the success of different surgical approaches to UPJO, and therefore the preservation of the renal function. However, a description of a record of improvement of renal function after the UPJO treatment has never been published before in the literature. We think that these findings provide enough evidence to choose laparoscopic pyeloplasty over laparoscopic nephrectomy in "limit patients", such as the elderly or those with kidneys with reduced FUR.

This study has several limitations to consider. Although it is a retrospective analysis, the cohort is small and there are other "candidates" to determine renal function recovery after laparoscopic pyeloplasty, such as the measurement of the glomerular filtration rate and imaging tests, including intravenous urography or ultrasound, this study may be a call for making larger and prospective studies to validate our findings and to compare different tools.

CONCLUSIONS {#S0005}
===========

Laparoscopic pyeloplasty is currently the gold standard for UPJO in our department. The MAG3 diuretic renography is the diagnostic tool of choice for patients with suspected UPJO and also for assessing the success or failure of surgical treatment.

Laparoscopic pyeloplasty not only corrects the UPJO, it may also recover renal function, demonstrated after a one year follow--up with diuretic renography. Laparoscopic pyeloplasty should be the procedure of choice even in those patients with poor renal function at diagnosis.
